These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 2790127)

  • 1. On repeated screening tests.
    Lau TS
    Biometrics; 1989 Sep; 45(3):891-8. PubMed ID: 2790127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. On dependent repeated screening tests.
    Lau TS
    Biometrics; 1991 Mar; 47(1):77-86. PubMed ID: 2049515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improving the diagnosis of bipolar disorder: predictive value of screening tests.
    Phelps JR; Ghaemi SN
    J Affect Disord; 2006 Jun; 92(2-3):141-8. PubMed ID: 16529822
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.
    Alonzo TA; Kittelson JM
    Biometrics; 2006 Jun; 62(2):605-12. PubMed ID: 16918926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of one-sample two-sided sequential t-tests for application in epidemiological studies.
    van der Tweel I; Kaaks R; van Noord PA
    Stat Med; 1996 Dec; 15(24):2781-95. PubMed ID: 8981686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening for allergic respiratory disease in the general population with the ADVIA Centaur Allergy Screen Assay.
    Linneberg A; Husemoen LL; Nielsen NH; Madsen F; Frølund L; Johansen N
    Allergy; 2006 Mar; 61(3):344-8. PubMed ID: 16436144
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy.
    Moghtaderi A; Bakhshipour A; Rashidi H
    Clin Neurol Neurosurg; 2006 Jul; 108(5):477-81. PubMed ID: 16150538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic efficacy of screening tests for hereditary hemochromatosis.
    Borwein S; Ghent CN; Valberg LS
    Can Med Assoc J; 1984 Oct; 131(8):895-901. PubMed ID: 6593112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
    Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
    J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interpretation of diagnostic data: 5. How to do it with simple maths.
    Can Med Assoc J; 1983 Nov; 129(9):947-54. PubMed ID: 6671182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnostic testing, pre- and post-test probabilities, and their use in clinical practice.
    Paulo S; Mendes S; Vizinho R; Carneiro AV
    Rev Port Cardiol; 2004 Sep; 23(9):1187-98. PubMed ID: 15587576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The value of the CAGE in screening for alcohol abuse and alcohol dependence in general clinical populations: a diagnostic meta-analysis.
    Aertgeerts B; Buntinx F; Kester A
    J Clin Epidemiol; 2004 Jan; 57(1):30-9. PubMed ID: 15019008
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The parameterization of predictive value for multisite screening.
    McHugh R; Church T; Mandel J; White C
    Biometrics; 1980 Sep; 36(3):523-9. PubMed ID: 7213914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results.
    Radack KL; Rouan G; Hedges J
    Arch Pathol Lab Med; 1986 Aug; 110(8):689-93. PubMed ID: 3755325
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictive value and efficiency of hematology data.
    Galen RS
    Blood Cells; 1980; 6(2):185-97. PubMed ID: 6769520
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening properties of questionnaires and laboratory tests for the detection of alcohol abuse or dependence in a general practice population.
    Aertgeerts B; Buntinx F; Ansoms S; Fevery J
    Br J Gen Pract; 2001 Mar; 51(464):206-17. PubMed ID: 11255902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statistical issues in the evaluation of screening and early detection modalities.
    Etzioni R
    Urol Oncol; 2008; 26(3):308-15. PubMed ID: 18452826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests.
    Baker SG; Kramer BS
    J Med Screen; 2008; 15(1):18-22. PubMed ID: 18416950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Test-retest reliability of wideband reflectance measures in infants under screening and diagnostic test conditions.
    Vander Werff KR; Prieve BA; Georgantas LM
    Ear Hear; 2007 Sep; 28(5):669-81. PubMed ID: 17804981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The diagnostic utility of multiple-level likelihood ratios.
    Bowden SC; Loring DW
    J Int Neuropsychol Soc; 2009 Sep; 15(5):769-76. PubMed ID: 19635177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.